Primary Business Development & Strategic Alliance Consultations
Strategic Planning
Potential Partner Screening and Initial Contact
Deal Negotiation
Strategic Marketing and Branding
Strategic Assistance
Technology Evaluation
Due Diligence
Market Research
Business Plan and Fund Raising
Nucleic acid-based therapeutic companies and functional genomics companies include:
AGY Therapeutics, Alkermes, Allele Biotechnology & Pharmaceuticals, Alnylam Pharmaceutical, Ambion, Anadys Pharmaceuticals, Archemix,Atugen AG, AVI Biopharma, Benitec Australia, Cenix Bioscience GmbH, Compugen, Deltagen, deVGen, Dharmacon,Epicentre, EpiGenesis Pharmaceuticals, Exelixis, Gen-Probe, Gene Therapy Systems, Genetica Inc., Genset SA and Genset Corporation, Genta, Hemispherx Biopharma, Hybridon, IBA GmbH, Imgenex, Immusol,Ingenium, International Therapeutics, Intradigm, Isis Pharmaceuticals, Lexicon Genetics, Millenium, Mirus, MWG Biotech AG, N.V. Organon, NascaCell GmbH Noxxon Pharma AG, Nucleonics, Phylonix, Phylos, PolyTransfection, Proligo, ProteoPlex, PTC Therapeutics, Qiagen, Regeneron, Rib-X Pharmaceuticals, Ribonomics, Ribopharma AG, Sirna Pharmaceuticals, Sequitur, Somagenics, SomaLogic, Vical, Xenogen, Xeragon(Qiagen).
Therapeutic antibody companies include:
Abgenix , AbTech, AERES Biomedical, Affibody, Affimed Therapeutics, Altarex, Atopix, Avanir/Xenerex, BioInvent, Biosite, Cambridge Antibody Technology (CAT), CellTech, Centocor, Chugai, Corvas, Crucell, CYTOS Biotechnology, Dyax, EluSys Therapeutics, ESBATech, Exelixis, Genentech, GeneTastix, GenMab A/S / Medarex, Human Genome Sciences, IDEC, ILEX Oncology, ImmunoGen, ImmunoMedics, Japan Tobacco, JARI Pharmaceuticals, Kirin Brewery, KS Biomedix, Kyowa Hakko Kogyo, Lexicon Genetics, MacroGenics, MedImmune, Morphosys, Oxford Biomedica, Peregrine Pharmaceuticals, Perlan, Procyon BioPharma, Protein Design Labs, Raven Biotechnologies, Sagres Discovery, Seattle Genetics, Symphogen, Tanox, XTL Biopharmaceuticals and ZymoGenetics.
Proteomics /genomics companies include:
Acadia Pharmaceuticals, ActivX Biosciences, Archemix, AxCell Biosciences, Biofrontera, Caprion, CellZome, Cogent Neuroscience, Compugen, Cytomyx, deCode Genetics, DeveloGen, Digital Gene Technologies, EGEA Genomics, EOS Biotechnology, EuroProteome, Galapagos Genomics, Genaissance, Geneva Proteomics, Genicon Sciences, GenOdyssee, Glaucus Proteomics, GPC Biotech, Hibergen, Hybrigenics, Inpharmatica, Large Scale Biology, Lynx Therapeutics, MDS Proteomics, Molecular Staging, Neogenesis, Neurome, NeuroTrophic, NextGen Sciences, Oasis Biosciences, Oxagen, Pharmagene, Phylos, Protein Pathways, Proteome Systems, Psychogenics, Quark Biotech Inc. (QBI), Rubicon Genomics, Sense Proteomic, Signature Bioscience, Structural GenomiX Inc. (SGI), SurroMed, Syrrx, UmanGenomics, Vita Genomics, Xenon Genetics, Zycos, and Zymogenetics.
BIG Pharma/BIG Biotech companies in Europe, North America include:
Abbott, Akzo Nobel / N.V. Organon, Alcon, Allergan, Amersham, Amgen, Applied Biosystems, Ares Serono, Asta Medica, Astra-Zeneca, Aventis / Aventis Pasteur, Baxter, Bayer, Beaufour-Ipsen, BD / Becton Dickinson, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Byk Gulden / Altana, Celera, Centocor / J&J, Cephalon, Chiesi, Chiron, Dompe, Elan, Eli Lilly & Co., Ferring AB, Fournier, Genentech, Genzyme, Gilead, GSK / Glaxo-SmithKline, Gruenenthal, H. Lundbeck, Human Genome Sciences, IDEC Pharmaceuticals, Incyte, Invitrogen, Johnson & Johnson / J&J / Ortho Biotech / Johnson & Johnson Pharmaceutical Research & Development, LLC., Leo Pharmaceutical, Ligand, MedImmune, Menarini, Merck & Co. (USA), Merck KGaA , Merckle, Novartis, Novo Nordisk, Orion Farmos, Perkin-Elmer, Pfizer / Pharmacia, Pierre Fabre Medicament, Procter & Gamble Pharmaceuticals, Protein Design Labs, Purdue Pharma, Recordati, Roche Bioscience, Roche / Hoffmann La-Roche, Sanofi-Synthelabo, Schering AG, Schering-Plough, Schwarz Pharma, Servier, Shire, Sigma-Tau Farmaceutiche, Solvay, UCB Pharma, Wyeth / American Home Products and Zambon Group.
In Asia-Pacific, BioMinerva Group covers mainland China, Taiwan, Hong Kong, Singapore, Japan and Australia.
In sum, you can rely on our global vision and reach to identify and access partnering, licensing and dealmaking opportunities worldwide. So don't limit your options -- contact us today!
